Dennis Wu

Dennis Wu has worked in a variety of roles in the biotechnology and medical fields since 2012. From 2012-2017, they were a Graduate Student Researcher at UC Davis, where they used a novel in vivo gene delivery system to study autophagic protein/cell signaling in bone remodeling, resulting in 6 publications in peer-reviewed journals and 6 scientific presentations at local and international conferences. Dennis also created illustrations and multimedia files, resulting in publications in the Journal of Visualization Experiment and a review article in Clinical Immunology. From 2017-2019, they were a Postdoctoral Fellow at the University of California, San Diego - School of Medicine, where they used their strong time management skills to lead an industry collaborative project with monthly progress presentations and secure >$94K lab funding. Dennis also led a collaborative project with microscopy specialists and students to study protein-protein interactions using cutting-edge imaging techniques. Finally, they applied proteomic and transcriptomic analysis to study cell signaling and disease mechanisms using human cells derived from patients, resulting in 3 manuscripts for peer review. Since 2019, they have been a Principal Scientist, Senior Scientist, and Scientist at Lynx Biosciences, Inc., a clinical-stage biotechnology company combining physiologically relevant suspension cell co-culture assays, automated microfluidics, and deep learning analytics with the goal of rapidly advancing drug candidates in oncology and bringing personalized cancer treatments to patients.

Dennis Wu obtained a B.S. in Biochemistry and Cell Biology from UC San Diego and a Doctor of Philosophy (Ph.D.) in Immunology from the University of California, Davis.